Advertisment
Laser Treatment for Periodontal Gum Disease; Silicon Valley Take Note!
Gum disease affects nearly half the adult population in the United States and with periodontal gum disease Silicon Valley is no exception. Laser treatment for periodontal gum disease in Silicon Valley is where Dr. Barney Lim uses cutting edge laser technology to treat gum disease. Oral health is critical to enjoying a high quality of life and overall well being. Chances are though, if this many people have some kind of gum condition already, many will experience the painful and dangerous symptoms of advanced gum disease.
Periodontal means “around the tooth” literally. Periodontal diseases such a periodontitis and gingivitis are rather serious infections and can lead to tooth loss if left untreated. Both the gums and bone that support the teeth are affected by these bacterial infections.
Just like any condition that is left untreated, a more advanced and detrimental form of that disease results. Over time, the more serious a gum health condition becomes, the more extensive a procedure is needed for treatment.
Bay area residents suffering from advanced gum disease have long had to rely on periodontal procedures that involve a lot of surgical cutting and stitching. This is an extremely painful experience which requires a lot of time to heal.
Fortunately, just as lasers have revolutionized the way optical procedures are performed, they have transformed the periodontal world as well. Bay Area’s own Dr. Barney Lim is the individual credited with using lasers to treat many forms of gum disease. His method is less painful than traditional treatments and doesn’t cause the same sensitivities as scalpel procedures. The spaces between the teeth remain more intact with laser treatments as well. To top it off, modern laser treatments are a less expensive alternative.
Now, more than ever, is the time for bay area residents to get their oral health on track. The thought of expensive and invasive surgical procedures should no longer deter someone suffering from gum disease from seeking help. Laser treatments are here at last.
Related Videos :
- New Periodontal Treatment Technology
Periowave™ Photodynamic Disinfection(PDD) is new technology in the fight against bacteria and virulence factors associated with periodontal diseases. Periowave™ is a broad-spectrum antimicrobial that combines advanced non-thermal diode laser technology with wavelength-matched photosensitizers to target the pathogens that scaling and root planing leave behind. Clinical studies have shown that Periowave in conjunction with SRP can significantly increase CAL, reduce bleeding, and reduce probing… From:
« view video » - Teeth Whitening Laser Periodontal Therapy Pros Cons
Teeth Whitening : Laser Periodontal Therapy Pros & Cons The pros and cons of laser periodontal therapy revolve around the elimination of decayed tissue and bacteria, but paired with the risk of failure to regenerate the bone and tissue loss. Weigh the pros and cons of laser periodontal therapy withtips from a licensed dental assistant in this free video on oral hygiene. Expert: Michelle McPhail Contact: www.MySolutionz.com Bio: Michelle McPhail has been a licensed
« view video » - Dark Chocolate and Periodontal Disease www MyChocolateMedicine com
www.MyChocolateMedicine.com Cold processed dark chocolate is known to have a huge effect on periodontal disease (gum disease) and dental health. This is because of huge amounts and types of anti-oxidants and bioflavonoids in dark chocolate and the inherent anti-bacterial and anti-inflammation properties of cold processed dark chocolate. This short video by a dentist talks about these benefits. There is only one company in the world that makes cold processed dark chocolate and they
« view video » - Stop Gum Disease w help from Drs Shelly Omar Kassam
Stop Gum Disease w/ help from Drs. Shelly & Omar Kassam At Yaletown Laser & Cosmetic Dentistry we are happy to provide state of the art Preventive Hygiene Services. Regular scheduled visits for hygiene treatment is essential to one' s oral and overall health. Our aim is to work in partnership with our clients to achieve and maintain a healthy mouth that will contribute to their overall quality of life and wellness. During
« view video » - PerioSim Haptics Based Periodontal Simulator
(2006) This program provides a visual overview of the haptics-based virtual reality periodontal training simulator application. A realistic 3-dimensional model of the human mouth is explored in real-time; the interface allows a user to adjust the model position, viewpoint, and transparency level, while using a haptics device providing force-feedback to realistically interact with the ' virtual' mouth. Various periodontal procedures are explored for the purpose of training
« view video »
Related News :
- NovaBay begins phase 2 study of Aganocide compound NVC 422 in impetigo
NovaBay Pharmaceuticals, Inc, a clinical stage company developing novel anti-infective compounds for the treatment or prevention of a wide range of bacterial, viral and fungal infections, announced the start of a phase-2a proof-of-concept study of its lead Aganocide compound NVC-422 in impetigo.
Read more » - Preclinical study results of using uncultured ADRCs to treat periodontitis reported
Cytori Therapeutics reported results from their preclinical study on the use of uncultured adipose-derived regenerative cells (ADRCs) in the treatment of critical periodontal defects in a rat model. The results suggest that the use of ADRCs may reverse the effects of periodontal disease, evidenced by significantly improved alveolar bone healing and decreased gingival (gum) invasion of the defect…
Read more » - NPG launches an online only open access journal Cell Death Disease
IWR News Desk, Information World Review , Monday 14 September 2009 at 12:18:00 Nature Publishing Group (NPG) along with the Associazione Differenziamento e Morte Cellulare is publishing an open access online journal called Cell Death & Disease in January 2010 The journal aims at exploring the area of cell death from a translational medicine perspective. It will be a peer-reviewed author-pays…
Read more » - Kanye West Bamboozles Taylor Swift At VMAs
Taylor Swift was relishing her unlikely win of best female video at the MTV Video Music Awards. The 19-year-old knew that the network doesn’t exactly make a habit out of giving their moonman trophies to country music stars. “I was standing on the stage and I was really excited because I had just won the award, ” Swift said after Sunday’s show at Radio City Music Hall. “And then I was really…
Read more » - Depression increases cancer patients risk of dying
Depression can affect a cancer patient’s likelihood of survival. That is the finding of an analysis published in the November 15, 2009 issue of Cancer, a peer-reviewed journal of the American Cancer Society. The results highlight the need for systematic screening of psychological distress and subsequent treatments.
Read more » - Every Day Cook Celi whack and proud
Loyal viewers of A and E TV well know the popular series, “Flip This House.” Denise Barkdoll has flipped her kitchen. After months of unexplained joint and muscle stiffness, pain and weight loss, the office manager at Northern Stainless was finally diagnosed with celiac disease about a year ago.
Read more » - Kanye Interrupts Swift At VMAs
Taylor Swift was relishing her unlikely win of best female video at the MTV Video Music Awards. “I was standing on the stage and I was really excited because I had just won the award… then I was really excited because Kanye West was on the stage. And then I wasn’t so excited anymore after that.”
Read more » - Kanye upset Jackson honored at MTV awards
ASSOCIATED PRESS NEW YORK Taylor Swift was relishing her unlikely win of best female video at the MTV Video Music Awards. The 19-year-old knew that the network doesn’t exactly make a habit out of giving their moonman trophies to country music stars. “I was standing on the stage and I was really excited because I had just won the award, ” Swift said after Sunday’s show at Radio City Music Hall…
Read more » - ARIAD Announces Result of First Interim Analysis of Phase 3 Succeed Trial of Oral Ridaforolimus Its Investigational
CAMBRIDGE, Mass.—-ARIAD Pharmaceuticals, Inc. today announced that the independent Data Monitoring Committee of the Phase 3 SUCCEED trial has completed the first interim efficacy analysis as specified by the study protocol and has recommended that the randomized, placebo-controlled trial of oral ridaforolimus in patients with metastatic sarcomas continue to full patient enrollment and…
Read more »